The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1
Open accessAbstract
Mutational escape by human immunodeficiency virus (HIV) from cytotoxic T-lymphocyte (CTL) recognition is a major challenge for vaccine design. However, recent studies suggest that CTL escape may carry a sufficient cost to viral replicative capacity to facilitate subsequent immune control of a now attenuated virus. In order to examine how limitations can be imposed on viral escape, the epitope TSTLQEQIGW (TW10 [Gag residues 240 to 249]), presented by two HLA alleles associated with effective control of HIV, HLA-B*57 and -B*5801, was investigated. The in vitro experiments described here demonstrate that the dominant TW10 escape mutation, T242N, reduces viral replicative capacity. Structural analysis reveals that T242 plays a critical role in defining the start point and in stabilizing helix 6 within p24 Gag, ensuring that escape occurs at a significant cost. A very similar role is played by Thr-180, which is also an escape residue, but within a second p24 Gag epitope associated with immune control. Analysis of HIV type 1 gag in 206 B*57/5801-positive subjects reveals three principle alternative TW10-associated variants, and each is strongly linked to concomitant additional variants within p24 Gag, suggesting that functional constraints operate against their occurrence alone. The extreme conservation of p24 Gag and the predictable nature of escape variation resulting from these tight functional constraints indicate that p24 Gag may be a critical immunogen in vaccine design and suggest novel vaccination strategies to limit viral escape options from such epitopes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116
Self-citationHIV evolution: CTL escape mutation and reversion after transmission
Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y., Holmes, E. C., Allen, T., Prado, J. G., et al. (2004) · Nature Medicine · doi:10.1038/nm992 · Cited by 847
Self-citationDominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P., Moore, C., Pfafferott, K. J., Hilton, L., et al. (2004) · Nature · doi:10.1038/nature03113 · Cited by 842
Self-citationEvidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S., & Mallal, S. A. (2002) · Science · doi:10.1126/science.1069660 · Cited by 740
Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid
Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I., & Hill, C. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81823-1 · Cited by 706 · cited 2×
“As with other epitopes associated with successful HIV/SIV control (4, 13, 14, 19), the capsid protein is a promising target for effective CTL, perhaps because of selection pressure against single escape mutations arising in the absence of linked compensatory changes.”
BackgroundAurora, R., & Rose, G. D. (1998) · Protein Science · doi:10.1002/pro.5560070103 · Cited by 697
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Barouch, D. H., Kunstman, J., Kuroda, M. J., Schmitz, J. E., Santra, S., Peyerl, F. W., Krivulka, G. R., Beaudry, K., Lifton, M. A., Gorgone, D. A., et al. (2002) · Nature · doi:10.1038/415335a · Cited by 661
HIV and SIV CTL escape: implications for vaccine design
Goulder, P. J. R., & Watkins, D. I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1417 · Cited by 500
Self-citationKelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.375 · Cited by 448
Self-citationFunctional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein
von Schwedler, U. K., Stray, K. M., Garrus, J. E., & Sundquist, W. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5439-5450.2003 · Cited by 421
Koenig, S., Conley, A. J., Brewah, Y. A., Jones, G. M., Leath, S., Boots, L. J., Davey, V., Pantaleo, G., Demarest, J. F., Carter, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0495-330 · Cited by 377
Reversion of CTL escape–variant immunodeficiency viruses in vivo
Friedrich, T. C., Dodds, E. J., Yant, L. J., Vojnov, L., Rudersdorf, R., Cullen, C., Evans, D. T., Desrosiers, R. C., Mothé, B. R., Sidney, J., et al. (2004) · Nature Medicine · doi:10.1038/nm998 · Cited by 369
Braaten, D., Franke, E. K., & Luban, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3551-3560.1996 · Cited by 334
Crystal structure of dimeric HIV-1 capsid protein
Momany, C., Kovari, L. C., Prongay, A. J., Keller, W., Gitti, R. K., Lee, B. M., Gorbalenya, A. E., Tong, L., McClure, J., Ehrlich, L. S., et al. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0996-763 · Cited by 319
Draenert, R., Le Gall, S., Pfafferott, K. J., Leslie, A. J., Chetty, P., Brander, C., Holmes, E. C., Chang, S.-C., Feeney, M. E., Addo, M. M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031982 · Cited by 304
Self-citationAllen, T. M., Altfeld, M., Yu, X. G., O'Sullivan, K. M., Lichterfeld, M., Le Gall, S., John, M., Mothe, B. R., Lee, P. K., Kalife, E. T., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7069-7078.2004 · Cited by 261
Self-citationConstruction and In Vitro Properties of SIV mac Mutants with Deletions in "Nonessential" Genes
GIBBS, J. S., REGIER, D. A., & DESROSIERS, R. C. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.333 · Cited by 256
Yusim, K., Kesmir, C., Gaschen, B., Addo, M. M., Altfeld, M., Brunak, S., Chigaev, A., Detours, V., & Korber, B. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8757-8768.2002 · Cited by 248
Matano, T., Kobayashi, M., Igarashi, H., Takeda, A., Nakamura, H., Kano, M., Sugimoto, C., Mori, K., Iida, A., Hirata, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040432 · Cited by 216
Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein
Tang, C., Ndassa, Y., & Summers, M. F. (2002) · Nature Structural Biology · doi:10.1038/nsb806 · Cited by 205
Berthet-Colominas, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1124 · Cited by 191
Fernandez, C. S., Stratov, I., De Rose, R., Walsh, K., Dale, C. J., Smith, M. Z., Agy, M. B., Hu, S.-L., Krebs, K., Watkins, D. I., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5721-5731.2005 · Cited by 173
Migueles, S. A., Laborico, A. C., Imamichi, H., Shupert, W. L., Royce, C., McLaughlin, M. E., Ehler, L. A., Metcalf, J. A., Liu, S., Hallahan, C. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6889-6898.2003 · Cited by 157
Gatanaga, H., Suzuki, Y., Tsang, H., Yoshimura, K., Kavlick, M. F., Nagashima, K., Gorelick, R. J., Mardy, S., Tang, C., Summers, M. F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108005200 · Cited by 156
Construction and In Vitro Properties of HIV-1 Mutants with Deletions in "Nonessential" Genes
Gibbs, J. S., Regier, D. A., & Desrosiers, R. C. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.343 · Cited by 141
HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response
Feeney, M. E., Tang, Y., Pfafferott, K. J., Roosevelt, K. A., Draenert, R., Piechocka‐Trocha, A., Yu, X. G., Verrill, C. L., Allen, T. M., Moore, C., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7524 · Cited by 109
Self-citationFriedrich, T. C., Frye, C. A., Yant, L. J., O’Connor, D. H., Kriewaldt, N. A., Benson, M., Vojnov, L., Dodds, E. J., Cullen, C., Rudersdorf, R. A., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2581-2585.2004 · Cited by 102
Gatanaga, H., Das, D., Suzuki, Y., Yeh, D. D., Hussain, K. A., Ghosh, A. K., & Mitsuya, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505920200 · Cited by 52
CTL responses to HIV and SIV: wrestling with smoke
John, M., & Mallal, S. A. (2005) · Nature Immunology · doi:10.1038/ni0305-232 · Cited by 6
Cited by
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235
Self-citationCD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Kiepiela, P., Ngumbela, K., Thobakgale, C., Ramduth, D., Honeyborne, I., Moodley, E., Reddy, S., de Pierres, C., Mncube, Z., Mkhwanazi, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1520 · Cited by 1,032
Self-citationDomingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Deeks, S. G., & Walker, B. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.010 · Cited by 759
Self-citation
Metadata
- Authors
- Martinez-Picado, J., Prado, J. G., Fry, E. E., Pfafferott, K., Leslie, A., Chetty, S., Thobakgale, C., Honeyborne, I., Crawford, H., Matthews, P., Pillay, T., Rousseau, C., Mullins, J. I., Brander, C., Walker, B. D., Stuart, D. I., Kiepiela, P., & Goulder, P.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-04
- Volume
- 80
- Issue
- 7
- Pages
- 3617-3623
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2053695022
- Cited by
- 446
- References
- 30
- FWCI
- 15.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.